Patents Assigned to Signet Laboratories
  • Use of ABP as a prognostic and diagnostic indicator
    Patent number: 6221611
    Abstract: This invention relates to the use of urine ABP measurement in the diagnosis of serious systemic infection, and in the determination of increased chance of mortality.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: April 24, 2001
    Assignee: Signet Laboratories, Inc.
    Inventor: Robert Silverman
  • Method for screening for prostate cancer by measuring apolipoprotein D levels in body fluid
    Patent number: 5804368
    Abstract: The invention is directed to a method for screening for possible prostate cancer presence. The method calls for assaying apolipoprotein D ("ApoD") levels in body fluids, such as serum. Assays for ApoD can be used prognostically, as well as diagnostically.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: September 8, 1998
    Assignee: Signet Laboratories
    Inventor: Wayne Tilley